Gallbladder Disease

Disease

Related News

GLP-1 Diabetes Drugs Draw Weight-Loss Demand and Safety Scrutiny

May 04, 2026

GLP-1 drugs used for type 2 diabetes and obesity are seeing rising demand for weight loss as safety concerns also draw attention. A 2025 WHO guideline said long-term safety data remains limited.

Semaglutide Reduces Heart Attack Risk Independent of Weight Loss, Study Finds

Feb 13, 2026

New research shows semaglutide cuts cardiovascular event risk by 4% per 5kg weight loss, with two-thirds of heart benefits unexplained by weight reduction alone. Study of 17,604 participants suggests multiple protective mechanisms beyond weight loss.